版本:
中国

BRIEF-Neogenomics says neolab liquid biopsy prostate test is more accurate than conventional biopsies

May 15 Neogenomics Inc:

* Neogenomics reports that its neolab(r) liquid biopsy prostate test is more accurate than conventional biopsies in predicting high grade prostate cancer

* Neogenomics-New clinical trial showed sensitivity of neolab liquid biopsy prostatetest was 97 pct in predicting presence of high grade prostate cancer Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐